Antiplatelet agents reduce risk of postoperative IOL bleeding

Article

The use of antiplatelet agents, such as aspirin and clopidogrel, are safer to use compared to anticoagulation (warfarin) therapy, according to the American Journal of Ophthalmology.

The use of antiplatelet agents, such as aspirin and clopidogrel, are safer to use compared to anticoagulation (warfarin) therapy, according to the American Journal of Ophthalmology.

Dr Jaeryung Oh et al., Department of Ophthalmology, Anam Hospital, Korea University College of Medicine, Seoul, Korea, conducted an observational, retrospective case control study on 822 patients who underwent vitreoretinal surgery in 1994, 2004 and 2008.

The outcome measures included the proportion using antiplatelets or anticoagulants, the occurrence of early postoperative intraocular bleeding in patients, and clinical outcomes of the haemorrhage.

The findings demonstrated that the rate of anticoagulant therapy didn't vary and lowers the risk of intraocular haemorrhage after vitrectomy.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.